Advertisement

Cancer and Metastasis Reviews

, Volume 37, Issue 4, pp 665–676 | Cite as

Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases

  • Michael A. SiroverEmail author
Article
  • 246 Downloads

Abstract

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) may represent the quintessential example of a moonlighting protein. The latter are a new, intriguing class of cell proteins which exhibit multiple activities in different subcellular locales apart from their initially, well-characterized function. As such, apart from its classical role in energy production, membrane-bound GAPDH is required for membrane fusion, endocytosis and, intriguingly, for iron transport. Cytoplasmic GAPDH regulates mRNA stability and is required for ER to Golgi trafficking. Nuclear GAPDH is involved in apoptosis, transcriptional gene regulation, the maintenance of DNA integrity, as well as nuclear tRNA export. Paradoxically, the etiology of a number of human pathologies is dependent upon GAPDH structure and function. In particular, recent evidence indicates a significant role for moonlighting GAPDH in tumorigenesis. Specifically, these include its role in the survival of tumor cells, in tumor angiogenesis, as well as its control of tumor cell gene expression and posttranscriptional regulation of tumor cell mRNA. Each of these activities correlates with increased tumor progression and, unfortunately, a poor prognosis for the afflicted individual.

Keywords

Glyceraldehyde-3-phosphate dehydrogenase Tumorigenesis Apoptosis Cancer angiogenesis Posttranscriptional mRNA regulation Cancer gene expression 

Notes

Funding information

Work in the author’s laboratory was funded by grants from the National Institutes of Health, the National Science Foundation, and by the W.W. Smith Charitable Trust.

References

  1. 1.
    Sirover, M. (2017). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH): the quintessential moonlighting protein in normal cell function and in human disease. London: Elsevier.Google Scholar
  2. 2.
    Huang, G., Lan, F., Zheng, Z., et al. (2011). Akt2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation. The Journal of Biological Chemistry, 286, 42211–42220.CrossRefGoogle Scholar
  3. 3.
    Jacquin, M., Chiche, J., Zunino, B., et al. (2013). GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death. Cell Death and Differentiation, 20, 1043–1054.CrossRefGoogle Scholar
  4. 4.
    Zhong, H., & Simons, J. (1999). Direct comparison of GAPDH, b-actin, cyclophilin and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochemical and Biophysical Research Communications, 259, 523–526.CrossRefGoogle Scholar
  5. 5.
    Lu, S., Gu, X., Hoestje, S., & Epner, D. (2002). Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochimica et Biophysica Acta, 1574, 152–156.CrossRefGoogle Scholar
  6. 6.
    Graven, K., Bellur, D., Klahn, B., Lowrey, S., & Amerger, E. (2003). HIF-2α regulates glyceraldehyde-3-phosphate dehydrogenase expression in endothelial cells. Biochimica et Biophysica Acta, 1626, 10–18.CrossRefGoogle Scholar
  7. 7.
    Higashimura, Y., Nakajima, Y., Yamaji, R., et al. (2011). Up-regulation of expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells. Archives of Biochemistry and Biophysics, 509, 1–8.CrossRefGoogle Scholar
  8. 8.
    Chiche, J., Pommier, S., Beneteau, M., et al. (2015). GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin’s B lymphomas via NF-κB-dependent induction of HIF-1α. Leukemia, 29, 1163–1176.CrossRefGoogle Scholar
  9. 9.
    Bonafé, N., Gilmore-Hebert, M., Folk, N., Azodi, M., Zhou, Y., & Chambers, S. (2005). Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-rich 3′ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: Possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Research, 65, 3762–3771.CrossRefGoogle Scholar
  10. 10.
    Zhou, Y., Yi, X., Stoffer, J., et al. (2008). The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer. Molecular Cancer Research, 6, 1375–1384.CrossRefGoogle Scholar
  11. 11.
    Kim, S., Lee, J., & Kim, J. (2007). Regulation of oncogenic transcription factor hTAFll68-TEC activity by human glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The Biochemical Journal, 404, 197–206.CrossRefGoogle Scholar
  12. 12.
    Liu, K., Tang, Z., Huang, A., et al. (2017). Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression. Int’l Journal of Oncology, 50, 252–262.CrossRefGoogle Scholar
  13. 13.
    Sirover, M. (1999). New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta, 1432, 159–184.CrossRefGoogle Scholar
  14. 14.
    Hara, M., Agrawal, N., Kim, S., et al. (2005). S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nature Cell Biology, 7, 665–674.CrossRefGoogle Scholar
  15. 15.
    Hu, G., Chung, Y.-L., Glover, T., Valentine, V., Look, A., & Fearon, E. (1997). Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics, 46, 103–111.CrossRefGoogle Scholar
  16. 16.
    Li, S., Li, Y., Carthew, R., & Lai, Z.-C. (1997). Photoreceptor cell differentiation requires regulated proteolysis of the transcriptional repressor Tramtrack. Cell, 90, 469–478.CrossRefGoogle Scholar
  17. 17.
    Tang, A., Neufeld, T., Kwan, E., & Rubin, G. (1997). PHYL acts to down-regulate TTK88, a transcriptional repressor of neuronal cell fates, by a SINA-dependent mechanism. Cell, 90, 459–467.CrossRefGoogle Scholar
  18. 18.
    Hara, M., & Snyder, S. (2006). Nitric oxide-GAPDH-Siah: a novel cell death cascade. Cellular and Molecular Neurobiology, 26, 527–538.CrossRefGoogle Scholar
  19. 19.
    Tristan, C., Ramos, A., Shahani, N., et al. (2015). Role of apoptosis signal-regulating kinase 1 (ASK1) as an activator of the GAPDH-Siah1 stress-signaling cascade. The Journal of Biological Chemistry, 290, 56–64.CrossRefGoogle Scholar
  20. 20.
    Sen, N., Hara, M., Kornberg, M., et al. (2008). Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nature Cell Biology, 10, 886–873.CrossRefGoogle Scholar
  21. 21.
    Kornberg, M., Sen, N., Hara, M., et al. (2010). GAPDH mediates nitrosylation of nuclear proteins. Nature Cell Biology, 12, 1094–1102.CrossRefGoogle Scholar
  22. 22.
    Chan, T. O., Rittenhouse, S. E., & Tsichlis, P. N. (1999). AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annual Review of Biochemistry, 68, 965–1014.CrossRefGoogle Scholar
  23. 23.
    Baba, T., Kobayashi, H., Kawasaki, H., Mineki, R., Naito, H., & Ohmori, D. (2010). Glyceraldehyde-3-phosphate dehydrogenase interacts with phosphorylated Akt resulting from increased blood glucose in rat cardiac muscle. FEBS Letters, 584, 2796–2800.CrossRefGoogle Scholar
  24. 24.
    Colell, A., Ricci, J.-E., Tait, S., et al. (2007). GAPDH and autophagy preserve survival after cytochrome c release in the absence of caspase activation. Cell, 129, 983–997.CrossRefGoogle Scholar
  25. 25.
    Semenza, G. (1999). Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annual Review of Cell and Developmental Biology, 15, 551–578.CrossRefGoogle Scholar
  26. 26.
    Graven, K., Yu, Q., Pan, D., Roncarati, J., & Farber, H. (1999). Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochimica et Biophysica Acta, 1447, 208–218.CrossRefGoogle Scholar
  27. 27.
    Silverthorne, C., & Alani, R. (2010). Glyceraldehyde-3-phosphate dehydrogenase expression is altered by hypoxia in melanoma cells and primary melanocytes. Melanoma Research, 20, 61–65.CrossRefGoogle Scholar
  28. 28.
    Said, H., Hagemann, C., Stojic, J., et al. (2007). GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol O Biologico, 8, 55.CrossRefGoogle Scholar
  29. 29.
    Said, H., Polat, B., Hagemann, C., et al. (2009). Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in-vitro. BMC Res Notes, 2, 8.CrossRefGoogle Scholar
  30. 30.
    Warburg, O. (1956). On the origin of cancer cells. Science, 123, 309–314.CrossRefGoogle Scholar
  31. 31.
    Labelle, Y., Bussieres, J., Courjal, F., & Goldring, M. (1999). The EWS/TEC fusion protein encoded by the t(9,22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene, 18, 3303–3303.CrossRefGoogle Scholar
  32. 32.
    Bradley, T., Stanley, E., & Sumner, M. (1971). Factors from mouse tissues stimulating colony growth of mouse bone marrow cells in vitro. The Australian Journal of Experimental Biology and Medical Science, 49, 595–603.CrossRefGoogle Scholar
  33. 33.
    Stanley, E., Guilbert, L., Tushinski, R., & Bartelmiz, S. (1983). CSF-1—a mononuclear phagocyte lineage-specific hemopoietic growth factor. Journal of Cellular Biochemistry, 21, 151–159.CrossRefGoogle Scholar
  34. 34.
    Baiocchi, G., Talpaz, M., Gutterman, J., et al. (1991). Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer, 67, 990–996.CrossRefGoogle Scholar
  35. 35.
    Chambers, S., Wang, Y., Gertz, R., & Kacinski, B. (1995). Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Research, 55, 1578–1585.Google Scholar
  36. 36.
    Wong, C., Temple, P., Leary, A., et al. (1987). Human CSF-1: molecular cloning and expression of a 4-kb cDNA encoding the human urinary protein. Science, 235, 1504–1508.CrossRefGoogle Scholar
  37. 37.
    Chambers, S., & Kacinski, B. (1994). Messenger RNA decay of macrophage colony-stimulating factor in human ovarian carcinomas in vitro. Journal of the Society for Gynecologic Investigation, 1, 310–316.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pharmacology, The Lewis Katz School of MedicineTemple UniversityPhiladelphiaUSA

Personalised recommendations